TAG:
test for prostate cancer
Health Insurers Want More Data On Clinical Utility of Molecular, Genetic Tests
CEO SUMMARY: Genetic tests that lack two essentials are troublesome for the nation’s health insurers. Those essentials are clinical validity and clinical utility. During a recent webinar, two executives from major health insurers stressed the need for genetic testing labs to provide acc…
CURRENT ISSUE
Volume XXIX, No. 16 – November 21, 2022
In an exclusive interview with The Dark Report, the founder of an innovative diagnostics company shares the firm’s new hybrid approach to collecting and analyzing blood samples, uniting the retail pharmacy and the clinical lab for both convenience and quality. In other news, an LIS company explains the steps needed to install a new LIS.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.